C

Convergent Therapeutics, Inc.

5 employees

Convergent Therapeutics is a pharmaceutical company that focuses on developing radiopharmaceutical therapies for prostate cancer.

Basic info

Industry

biotechnology research

Sectors

Health Care
Medical
Pharmaceutical

Date founded

2021

Funding rounds raised

Total raised

$90M

from 3 investors over 3 rounds

C

Convergent Therapeutics, Inc. raised $90M on May 3, 2023

Investors: The Invus Group, RA Capital Management, L.P. and OrbiMed Advisors

FAQ